Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Hyperfine, Inc. (NASDAQ:HYPR) have been given a consensus rating of “Hold” by the five ratings firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $2.0333.

Several brokerages have recently commented on HYPR. Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a report on Friday, July 17th. BTIG Research assumed coverage on shares of Hyperfine in a research note on Wednesday, April 29th. They issued a “buy” rating and a $2.00 target price on the stock. Finally, B. Riley Financial reiterated a “buy” rating and set a $1.60 target price (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th.

Hyperfine Stock Performance

NASDAQ HYPR opened at $0.90 on Tuesday. The company’s 50 day simple moving average is $1.16 and its two-hundred day simple moving average is $1.24. The company has a debt-to-equity ratio of 0.36, a current ratio of 6.15 and a quick ratio of 5.45. Hyperfine has a 1 year low of $0.85 and a 1 year high of $2.22. The stock has a market capitalization of $95.00 million, a PE ratio of -2.36 and a beta of 1.43.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) EPS for the quarter, meeting analysts’ consensus estimates of ($0.09). The firm had revenue of $3.90 million during the quarter, compared to analyst estimates of $4.13 million. Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. Analysts predict that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

A number of hedge funds and other institutional investors have recently modified their holdings of HYPR. EP Wealth Advisors LLC bought a new stake in Hyperfine in the 4th quarter worth $34,000. Sanctuary Advisors LLC raised its stake in shares of Hyperfine by 130.9% during the fourth quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after acquiring an additional 22,638 shares during the last quarter. Millennium Management LLC bought a new position in shares of Hyperfine during the fourth quarter valued at about $55,000. Cerity Partners LLC purchased a new stake in shares of Hyperfine during the fourth quarter worth about $59,000. Finally, Tortoise Investment Management LLC boosted its holdings in shares of Hyperfine by 60.0% during the fourth quarter. Tortoise Investment Management LLC now owns 72,000 shares of the company’s stock worth $71,000 after purchasing an additional 27,000 shares during the period. Institutional investors own 15.03% of the company’s stock.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.